Figure 5.Time-dependent ROC illustrating the accuracy of Masaoka stage, BRRS, and CRS for predicting the RFS at 3 years (A) and 5 years (B). (n = 120 THYM samples).
Figure 5 — A novel immune-related microRNA signature for prognosis of thymoma | Aging
